Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Biemond

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Rheumatology|August 26, 1998
Levels of circulating cellular fibronectin are increased in patients with rheumatoid vasculitisA E Voskuyl, J J Emeis, J M Hazes, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID useM Janssen, B A Dijkmans, J P Vandenbroucke, et al.
Digestive Diseases and Sciences|August 1, 1996
Gastric mucosal plasminogen activators in Helicobacter pylori infectionJ M Götz, Y Vergouwe, H W Verspaget, et al.
Journal of Clinical Pathology|September 29, 2004
Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitisW P ter Beek, E S M Muller, R A Van Hogezand, et al.
Tissue Antigens|July 1, 1980
HLA antigen distribution and HLA haplotype segregation in Crohn's diseaseA S Peña, I Biemond, G Kuiper, et al.
Neuropeptides|July 3, 2007
Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistryW P ter Beek, I Biemond, E S M Muller, et al.
European Journal of Clinical Investigation|February 18, 2003
Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritisS Sanduleanu, A D E Bruïne, I Biemond, et al.
Gut|May 1, 1997
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutasesJ M Götz, J L Thio, H W Verspaget, et al.
Hepato-Gastroenterology|August 1, 1989
Immunological findings in whole and parotid saliva of patients with ulcerative colitis and healthy controlsG Crama-Bohbouth, A S Peña, H W Verspaget, et al.
Italian Journal of Gastroenterology and Hepatology|February 12, 2000
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negativeD Jonkers, P Houben, W Hameeteman, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Rheumatology|August 26, 1998
Levels of circulating cellular fibronectin are increased in patients with rheumatoid vasculitisA E Voskuyl, J J Emeis, J M Hazes, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID useM Janssen, B A Dijkmans, J P Vandenbroucke, et al.
Digestive Diseases and Sciences|August 1, 1996
Gastric mucosal plasminogen activators in Helicobacter pylori infectionJ M Götz, Y Vergouwe, H W Verspaget, et al.
Journal of Clinical Pathology|September 29, 2004
Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitisW P ter Beek, E S M Muller, R A Van Hogezand, et al.
Tissue Antigens|July 1, 1980
HLA antigen distribution and HLA haplotype segregation in Crohn's diseaseA S Peña, I Biemond, G Kuiper, et al.
Neuropeptides|July 3, 2007
Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistryW P ter Beek, I Biemond, E S M Muller, et al.
European Journal of Clinical Investigation|February 18, 2003
Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritisS Sanduleanu, A D E Bruïne, I Biemond, et al.
Gut|May 1, 1997
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutasesJ M Götz, J L Thio, H W Verspaget, et al.
Hepato-Gastroenterology|August 1, 1989
Immunological findings in whole and parotid saliva of patients with ulcerative colitis and healthy controlsG Crama-Bohbouth, A S Peña, H W Verspaget, et al.
Italian Journal of Gastroenterology and Hepatology|February 12, 2000
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negativeD Jonkers, P Houben, W Hameeteman, et al.
Pageof 12